000			01587nam a2200133Ia 4500
008			220620s9999||||xx |||||||||||||| ||und||
020			_a9783040000000
245		0	_aGynaecological Cancers Risk _bBreast Cancer, Ovarian Cancer and Endometrial Cancer
546			_aEnglish[eng]
650			_abreast cancer||galectins||galectin-7||galectin-8||prognostic markers||tumor infiltrating macrophages||screening||mammography||incidence-based mortality||population genetic testing||ovarian cancer risk||risk stratification||BRCA1||BRCA2||RAD51C||RAD51D||BRIP1||SNP||risk modelling||BRCA||population testing||cost-effectiveness||ovarian cancer||cancer prevention||CA125||HE4||UKCTOCS||MMT||postmenopausal women||rare germline variants||susceptibility genes||genomics||questionnaires||attitudes||symptoms||early detection||risk assessment||diagnostic prediction model||triage tool||ovarian cancer symptoms||family history||risk||genes||prevention||dyskerin||DKC1||endometrial cancer||telomerase||proliferation||telomeres||obesity||metabolomics||liquid biopsy||mass spectrometry||plasma biomarkers||artificial intelligence||ultrasound||TVS||trial||randomised controlled trial||genomic sequencing||tumor mutational signatures||hereditary cancer genes||mismatch repair||familial cancer||menopausal hormone therapy||breast cancer risk||BMI||early BMI||age of pregnancy||mammographic density||body mass index||weight loss||breast cancer prevention||premenopausal||genetic testing||germline||somatic||n/a
700			_aManchanda, Ranjit
856			_uhttps://mdpi.com/books/pdfview/book/4889
942			_cEB
999			_c31237 _d31237